Clinical trial
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed…
NCT00003725 · Anthra Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00003725 |
|---|---|
| Title | Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer |
| Official title | Phase III Randomized Study of a Single Adjunctive Instillation of Intravesical AD 32 (N-Trifluoroacetyladriamycin-14-valerate) Versus No Adjunctive Therapy Immediately Following Transurethral Resection in Patients With Multiple Superficial (Ta/T1) Bladder Tumors |
| Lead sponsor | Anthra Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure |
| Interventions | valrubicin, conventional surgery |
| Enrollment | 300 |
| Start date | Dec 1, 1996 |
| First posted | Jul 22, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: